MARKETS LIVE: Sensex up 150 pts, Nifty nears 10,900 ahead of US Fed outcome

MARKETS LIVE: Indices to eye US Fed policy decision todayTop gainers from the Nifty50 index COMPANY LATEST PREV CLOSE GAIN() GAIN(%) VOLUME DR REDDY’S LABS 2265.00 2190.65 74.35 3.39 2117052 CIPLA 582.65 567.10 15.55 2.74 4055906 TCS 1826.80 1781.00 45.80 2.57 4295569 HINDALCO INDS. 246.35 240.65 5.70 2.37 4361193 LUPIN 873.95 855.00 18.95 2.22 5572465 Click here for more gainers Global oil demand to grow steadily in 2019 but trade risks loom: IEA Oil demand will grow steadily in 2019 thanks to a solid global economy and stable prices, although trade tensions remain the largest risk, the International Energy Agency said on Wednesday. READ MORE   Market Check   S&P BSE Sensex 35,825.09 0.37%   Nifty 50 10,877.40 0.32%   S&P BSE 200 4,714.00 0.34%   Nifty 500 9,412.55 0.28%   S&P BSE Mid-Cap 16,163.30 0.08%   S&P BSE Small-Cap 17,102.90 0.22% Infosys hits record high on the BSE Shares of Infosys hit a record high of Rs 1,278.55 per share, up 1.6% on the BSE in intra-day trade on Wednesday, surpassing their previous high of Rs 1,278 per share recorded on June 3, 2016.   On the National Stock Exchange (NSE), the stock hit a high of Rs 1,278.85, up 1.6%, and is slightly away from its all-time high of Rs 1,279.30 touched on June 3, 2016. READ MORE Dr Reddy’s stock: Product pipeline should boost revenue growth in FY19   The Dr Reddy’s stock gained on Tuesday over 5 per cent in trade, on expectation that the company would be soon launching a generic version of opioid treatment drug Suboxone. Coupled with its other launches in FY19 in the US, this should boost its profit.   Analysts at Nomura believe there is a strong probability that the company will get approval in the near term for Suboxone, and expect initially lower competitive intensity. They estimate an annualised earnings per share impact of Rs 62.5 without additional generic competition. READ MORE Page Industries extends license agreement with Jockey; stock surges 6%   Shares of Page Industries hit a record high of Rs 26,180 per share, rising 6% on the BSE in intra-day trade after the company announced extension of license agreement with Jockey International till December 31, 2040.   “Our license agreement with Jockey International Inc has been extended till December 31, 2040,” Page Industries said in a regulatory filing. READ MORE
Source: Business Standard